SecBot SecBot
425 ·Filed Oct 16, 2026

MDXG

MIMEDX GROUP, INC.
MIXED
Impact 5/10
Horizonweeks Processed1mo ago SEC0001213900-26-110047
Rule 425 M&A communications
Actionable Insight ◆ Mixed

The FTC Second Request signals heightened antitrust scrutiny but is common in healthcare M&A. Watch for the timing of substantial compliance and any subsequent FTC action (clearance, consent decree, or challenge). A prolonged review beyond 60-90 days would increase deal risk.

DirectionMixed
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$4.43
T+0 close · Oct 16, 2026 · via day close
Latest settled
−26.86%
T+20 · $3.24 · next T+60 in 8w
Vs SPY
−25.70%
α at T+20
Latest observation
−29.07%
T+21 · FF3 residual α
  1. T+0 · Oct 16 $4.43entry
  2. T+1 · 29d ago −1.13%α −1.55% · $4.38
  3. T+5 · 25d ago −11.74%α −11.83% · $3.91
  4. T+20 · 4d ago −26.86%α −25.70% · $3.24
  5. T+21 · todayOpen
  6. T+60 · in 8w Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

MiMedx and Sanara each received a Second Request from the FTC on October 15, 2026, extending the HSR Act waiting period for their pending merger. The Second Request delays the close by at least 30 days after substantial compliance, introducing regulatory uncertainty but not a deal-breaker. The filing confirms both parties are cooperating with the FTC, and no deal terms have changed.

Key Financial Metrics

Deal Type
merger

Key Facts

  • MiMedx and Sanara each received a Second Request from the FTC on October 15, 2026.
  • The Second Request extends the HSR waiting period until 30 days after substantial compliance, unless extended or terminated earlier.
  • Completion of the merger remains subject to HSR clearance and other closing conditions.
  • The company states it continues to work constructively with the FTC.
  • No changes to deal terms, consideration, or timeline beyond the Second Request were disclosed.

Financial Impact

No financial figures disclosed; the Second Request introduces a delay of at least 30 days to closing, creating uncertainty but no direct financial impact.

Risk Factors

  • FTC could challenge the merger or impose conditions that alter deal economics.
  • Extended HSR review could delay close beyond expectations, creating financing or operational uncertainty.
  • If the deal fails to close, MiMedx may face integration costs or strategic setback.

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
425 Filing (Primary)0001213900-26-110047
Document: 0001213900-26-110047-index-headers.html0001213900-26-110047
Document: 0001213900-26-110047-index.html0001213900-26-110047
Document: 0001213900-26-110047.txt0001213900-26-110047

Track record

10 reports on MDXG

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +26.86% at T+20 after the Oct 16, 2026 report. 4 of 5 went positive at some point.

Filters
  1. Nov 12, 20264d ago SC 13G Neutral 4/10 Entry $3.21 Now $3.18 −0.93% settles Nov 20
  2. Oct 28, 202619d ago 8-K Bearish 6/10 No price data
  3. Oct 28, 202619d ago Press Release Bearish 6/10 Entry $3.97 to $3.28 Now $3.18 +19.90% ▲ +17.38% +12.65% vs SPY
  4. Oct 28, 202619d ago Press Release Bullish 5/10 Entry $3.97 to $3.28 Now $3.18 −19.90% ▼ −17.38% −12.65% vs SPY
  5. Oct 16, 20264w ago 425 Mixed 5/10 Viewing Entry $4.43 to $3.91 Now $3.18 −28.22% ▼ −11.74% −11.83% vs SPY
  6. Oct 16, 20264w ago 8-K Bearish 6/10 Entry $4.43 to $3.91 Now $3.18 +28.22% ▲ +11.74% +11.83% vs SPY
  7. Jun 2, 202624w ago Court Ruling Bullish 5/10 Entry $3.57 to $3.71 Now $3.18 −10.92% ▲ +3.92% +6.89% vs SPY
  8. Apr 29, 202628w ago DEFA14A Neutral 3/10 Entry $3.36 to $3.66 Now $3.18 −5.36% ▲ +8.93% +7.20% vs SPY
  9. Apr 22, 202629w ago Press Release Neutral 1/10 Entry $3.31 to $3.27 Now $3.18 −3.93% ▼ −1.36% −1.41% vs SPY
  10. Apr 16, 202630w ago 8-K Bearish 7/10 Entry $3.43 to $3.35 Now $3.18 +7.29% ▲ +2.33% +3.32% vs SPY
Showing 10 of 10

US Market Status

Market Closed · Opens in 6h 13m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 16, 2026